Attenuation of the Vasoconstrictor Action of Neuropeptide-Y by Calcium-Channel Blockers

Abstract

Neuropeptide-Y (NPY) was administered intracoronarily in dogs to see the modification of its vasoconstrictor action by the calcium (Ca)-channel blockers nisoldipine (0.1 μg/kg) and nifedipine (1 μg/kg).

Dogs were anesthetized and the left circumflex artery was cannulated with out opening the chest by using a specially designed cannula perfused at constant pressure. The change in coronary flow due to NPY was determined before and after the systemic administration of the two Ca-channel blockers. With adminis tration of 1 to 2 nmol of NPY, coronary blood flow decreased maximally by 23.4±7.8% without changes in perfusion pressure or central venous pressure and it became significantly less after nisoldipine: 16.0±5.7% (p < 0.02). A simi lar attenuation in the decrease in coronary flow was observed in the nifedipine study: 23.2±7.5% to 12.0±6.7% (p < 0.02). A fall in systemic arterial blood pressure was observed after administration of both Ca-channel blockers, but it was significant only after nisoldipine (p < 0.01). Nonsignificant increases in heart rate were observed after both drugs.

Nisoldipine seemed to attenuate the NPY-induced vasoconstriction in dogs, and its equimolar potency is about ten times that of nifedipine.

Get full access to this article

View all access options for this article.

References

Prinzmetal M. , Kennamer R. , Merliss R. , et al: Angina pectoris. I. A variant form of angina pectoris. Am J Med 27:375-388, 1959.

Yasue H. , Touyama M. , Kato H. , et al: Prinzmetal's variant form of angina pectoris as a manifestation of alpha-adrenergic coronary artery spasm: Demonstration by coronary arteriography . Am Heart J 91:148-155, 1976.

Chierchia S. , Davies G. , Berkenbom G. , et al: Alpha-adrenergic receptors and coronary spasm: An elusive link? Circulation 69:8-14, 1982.

Winnifold MD , Filipchuk N. , Hillis LD : Alpha-adrenergic blockade for variant angina: A long-term double blind, randomized trial. Circulation 67:1185-1188, 1983.

Chierchia S. , DeCasterina R. , Crea F. , et al: Failure of thromboxane A2 blockade to prevent vasospastic angina. Circulation 66:702-709, 1982.

Freedman SB , Chierchia S. , Rodriguez-Plaza L. , et al: Ergonovine-induced myocardial ischemia: No role for serotonergic receptors? Circulation 70:178-183, 1984.

Chierchia S. , Patorono C. , Crea F. , et al: Effects of intravenous prostacyclin in variant angina. Circulation 65:470-477, 1982.

Aizawa Y. , Murata M. , Hayashi M. , et al: Vasoconstrictor effect of neuropeptide Y (NPY) on canine coronary artery. Jpn Circ J 49:584-588, 1985.

Hayashi M. , Aizawa Y. , Satoh M. , et al: Effect of nifedipine on neuropeptide Y-induced vasoconstriction in anesthetized dogs. Jpn Heart J 27:251-267, 1986.

10.

Aizawa Y. , Satoh M. , Miyajima M. , et al: Potency and receptors involved in the vasoconstriction caused by neuropeptide Y. Jpn Heart J 28:891-898, 1987.

11.

Fleckenstein-Grun G. , Frey M. , Makita Y. , et al: New pharmacological aspects of various dihydropyridine calcium antagonists with regard to smooth muscle relaxation . In: Recent Aspects in Calcium Antagonism , ed. by Lichtlen PR. Stuttgart- New York: Schattuer , 1985, pp 29-46.

12.

Fleckenstein-Grun G. , Frey M. , Fleckenstein A. : Calcium antagonists: Mechanism and therapeutic uses. Trends Parmacol Sci 5:283-286, 1984.

13.

Maseri A. , Chierchia S. : Coronary spasm. Demonstration, definition, diagnosis and consequences . Prog Cardiovasc Dis 25:169-192, 1982.

14.

Tatemoto T. , Garlquist M. , Mutt V. : Neuropeptide Y — a novel peptide with structural similarities to peptide YY and pancreatic peptide. Nature 296:659-661, 1983.

15.

Clark LG , Davis GJ , Kerwin R. , et al: Coronary artery infusion of neuropeptides Y in patients with angina pectoris. Lancet ii:1057-1058, 1987 .

16.

Gu J. , Polak JM , Adrian TE, et al: Neuropeptide tyrosine (NPY)-a major cardiac neurotransmitter. Lancet i:1008-1010, 1983 .

17.

Edvisson L. , Emson P. , McCulloth J. , et al: Neuropeptide Y: Cerebral vascular innervation and vasospastic effect in the cat. Neurosci Letters 43:78-82, 1983.

18.

Pernow J. : Release and functional interaction of neuropeptide Y and noradernaline in physiological sympathetic vascular control. Acta Physiol Scand 56 (Suppl):1-56, 1988.